Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metallgesellschaft AG was a prominent German industrial conglomerate founded in 1881, historically centered on mining, non-ferrous metals, and engineering. During the late 20th century, the company maintained a significant presence in the life sciences and healthcare sectors through its ownership of Dynamit Nobel, which included the pharmaceutical division Madaus. The group also operated Lurgi, an engineering firm specializing in process technology for the chemical and pharmaceutical industries, and Chemetall, a leader in specialty chemicals. Following a major financial crisis in 1993 involving oil futures, the company underwent a comprehensive restructuring to focus on industrial technology. It was eventually renamed mg technologies ag in 2000 and became GEA Group AG in 2005. Today, its successor GEA Group is a leading global provider of equipment and process technology for the pharmaceutical and food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metallgesellschaft.